MediClin AG
- WKN: 659510
- ISIN: DE0006595101
- Land: Deutschland
Nachricht vom 11.05.2012 | 09:46
MediClin AG: Sales increased by EUR 5.4 million in the first Quarter of 2012
|
MediClin AG / Key word(s): Quarter Results Sales increased by EUR 5.4 million in the first Quarter of 2012 Offenburg, May 11, 2012 - MEDICLIN Aktiengesellschaft (MediClin) achieved Group sales of EUR 125.4 million in the first three months of the new financial year. Sales were EUR 5.4 million or 4.5 % higher than in the first quarter of 2011. The largest part of the increase was recorded in the post-acute segment. Here sales increased by EUR 4.4 million up to EUR 70.7 million. Sales of the acute segment sales rose by EUR 0.2 million up to EUR 50.6 million. The business area nursing care improved sales by EUR 0.3 million up to EUR 3.2 million. The Group operating result for the first quarter 2011 stood at EUR -0.5 million and included an aperiodic provision for budged risks in the amount of EUR 1.1 million. Adjusted for this special effect, the Group operating result for the first quarter 2012, which amounted EUR -1,2 million, is EUR 0.5 million higher than the figure achieved in the previous year. In the post-acute segment the result improved compared to the first quarter 2011 from EUR -3.3 million to EUR -1.7 million; in the acute segment it degreased by EUR 2.2 million to EUR 2.4 million due to increased costs. The financial result enhanced by EUR 0,3 million, therefore the result attributable to the shareholders of EUR -2,0 million was at the same level as in the first quarter 2011 lag. Further company development and outlook In 2012 MediClin will invest in a further expansion of capacities and in an extension of medical services offered based on corresponding demand. On Group level between MediClin and Askelpios the analysis of possible common potentials available has started as well as discussions about location-specific cooperation between the facilities of both holding companies. Overall, the Management Board expects an increase in sales in the current financial year and a solid development of results, insofar as the framework conditions in the industry and the referral behaviour of the coverage providers do not seriously change in 2012. The interim report of the first quarter 2012 is available in German and English at www.mediclin.de.
About MediClin AG (Ticker: MED; WKN: 659 510) MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 11 Medizinische Versorgungs-zentren (medical care units) in 11 federal states MediClin has a total capacity of approximately 8,100 beds. MediClins' facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,300 employees. End of Corporate News 11.05.2012 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de |
| Language: | English | |
| Company: | MediClin AG | |
| Okenstraße 27 | ||
| 77652 Offenburg | ||
| Germany | ||
| Phone: | +49 (0)781 488-189 | |
| Fax: | +49 (0)781 488-184 | |
| E-mail: | alexandra.muehr@mediclin.de | |
| Internet: | www.mediclin.de | |
| ISIN: | DE0006595101 | |
| WKN: | 659510 | |
| Listed: | Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart | |
| End of News | DGAP News-Service |
| 169357 11.05.2012 |
Interaktiv
Weitere News
-
17.05.13 17:00
MediClin AG: Chance in the Management Board of ... -
03.05.13 09:00
MediClin AG: Quarterly Group result below prev ... -
11.04.13 15:12
MEDICLIN Aktiengesellschaft: Bekanntmachung de ... -
22.03.13 17:09
MediClin AG: FY 2012 final results and busines ... -
22.03.13 15:22
MediClin AG: Vorstellung des Jahresabschlusses ...
Anleihe im Fokus
7,75% p.a. - Rendite aus Familienhand
– Zeichnungsstart: 23. Mai – Börse Frankfurt
– Zeichnung ab 1.000 Euro
– Laufzeit 5 Jahre
– WKN: A1TNA7
– 100% Rückzahlungskurs
GBC-Fokusbox
Syzygy AG: Aktie kaufen
Die nach den ersten drei Monaten des laufenden Jahres von Syzygy präsentierten Zahlen liegen im Rahmen unserer Erwartungen. Angesichts unserer unveränderten Prognosen behalten wir das bisherige Kursziel von 5 € bei und erneuern das Rating KAUFEN.
Event im Fokus
38. m:access Analystenkonferenz München
Datum: 06.06.2013
Zeit: 9:30 Uhr - 17.00 Uhr
Ort: Börse München
Der AKTIONÄR News

24. Mai 16:45 DAX schließt im Minus: Amadeus Fire, Bayer, BVB, Commerzbank, ...
24. Mai 16:30 Ist die Rallye vorbei? Max Otte und 4 weitere Top-Experten sagen, was ...
24. Mai 15:35 Dialog Semiconductor: Aktie im Korrekturmodus
24. Mai 15:00 Apple fällt, Ausnahmeaktie steigt: Gericht sorgt für Kurssprung
24. Mai 14:22 Freenet: Kurseinbruch wegen Dividende
Aktuelle Research-Studie
Original-Research: getgoods.de Anleihe (von GBC AG): stark überdurchschnittlich attraktiv getgoods.de Anleihe
24. Mai 2013